21 WiSys Technologies in "Micro & Nanotech" or "Agriculture" or "Information Technology" or "Pharmaceuticals & Vitamin D" or "Research Tools"
WiSys is seeking strategic partners interested in the commercial use of this innovation.
WiSys is seeking strategic partners interested in the commercial use of this innovation
WiSys is currently seeking development partners for the optimization of the prototype and adhesive, as well as strategic partners for its manufacture who could provide a route to market for commercialization.
Researchers from the University of Wisconsin - Stevens Point are part of a multi-institution research team that has developed a vaccine with proven efficacy in preventing Francisella infections in fish.
Stimuli-Responsive Smart Block Copolymers Improve Dispersion of Titanium Dioxide in Architectural Coatings
WiSys is currently seeking strategic partners in the coatings industry that are interested in co-development opportunities that would ultimately provide a route to market for commercialization of these novel copolymers.
WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system. There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.
WiSys is currently seeking strategic partners in the next generation transistor industry that are interested in further optimizing the design for large-scale manufacturing, ultimately providing a path to market for its commercialization.
WiSys is seeking a strategic commercial partner for development of this beehive wind shield for mass manufacturing, as well as partners for marketing, sales, and distribution.
WiSys Technology Foundation is seeking a strategic partner with an industry player in the life science tools and reagents industry for the further development and commercialization of its novel monomeric fluorescent protein.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.